We have established training and research connections with the National Health Service (NHS) and other healthcare delivery stakeholders to translate scientific innovation into benefits for patients. Clinicians, researchers and healthcare companies can work with each other and with patients, to get new ideas from ‘bench to bed’ as quickly as possible.
For example, our Victor Phillip Dahdaleh Heart & Lung Research Institute (VPD-HLRI) is a collaboration between the University of Cambridge and the National Health Service (NHS), that brings together population health, laboratory, and clinical researchers, with patients and their loved ones, the NHS, commercial, and charitable sectors.
Key healthcare partners
Case studies
Early Crohn's treatment 'could save NHS millions'
Dr Nuru Noor, Prof Miles Parkes, and colleagues from Cambridge found using biologic drugs like Infliximab soon after diagnosis, rather than when symptoms worsen, was five times more effective at controlling the disease. This could save the NHS millions of pounds and significantly improve patients' quality of life.
New drug offers potential cure for ultra rare inherited condition
Mary Catchpole from Norfolk has become the first patient in Europe to be given a newly licensed treatment, which could potentially cure her life-threatening, inherited disorder, Activated PI3-kinase Delta Syndrome (APDS). Hear from Mary's consultant Dr Anita Chandra at Addenbrooke's and Prof Sergey Nejentsev who led the research at Cambridge that discovered APDS.
